PWMG
ONC

Prestige Wealth Management Group’s BeOne Medicines Ltd ONC Stock Holding History

Prestige Wealth Management Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-13
Closed -$2K – 1174
2018
Q4 		$2K Buy
+13
New +$1.72K ﹤0.01% 899

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Prestige Wealth Management Group's ONC Position: Q1 2019 in Review

Prestige Wealth Management Group sold out of BeOne Medicines Ltd (ONC) in Q1 2019, closing a stake of 13 shares — an estimated $2K sold.

Prestige Wealth Management Group first reported a position in ONC in Q4 2018 and held it in 1 quarter. The position peaked at $2K in Q4 2018. 199 funds tracked by Wall St. Rank hold ONC as of Q1 2019.

  • Prestige Wealth Management Group reported no remaining BeOne Medicines Ltd position as of Q1 2019 after selling out during the quarter.
  • Prestige Wealth Management Group sold 13 BeOne Medicines Ltd shares in Q1 2019, an estimated $2K.
  • Prestige Wealth Management Group first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 1 quarter.
  • Prestige Wealth Management Group's BeOne Medicines Ltd position peaked at $2K in Q4 2018.
  • 199 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2019.

Based on Prestige Wealth Management Group's 13F filing for Q1 2019, filed 16 Aug 2019.